Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021
Open accessAbstract
In Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We evaluated short-term vaccine effectiveness and found the vaccine to be highly effective among this population in this setting.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Vaccine efficacy against Covid-19 from 7 days to 6 months after the second dose was 91%, with similar estimated real-world effectiveness from 8 to 28 days after the second dose.
“Vaccine efficacy against Covid-19 from 7 days to 6 months after the second dose was 91%,6 with a similar estimated real-world effectiveness from 8 to 28 days after the second dose.7”
From Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age (2022) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108891 · Cited by 2,889 · see citing works
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., Hernán, M. A., Lipsitch, M., Reis, B., & Balicer, R. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101765 · Cited by 2,527 · see citing works
Safety, immunogenicity, and efficacy of the BNT162b2 covid-19 vaccine in adolescents
Frenck, R. W., Klein, N. P., Kitchin, N., Gurtman, A., Absalon, J., Lockhart, S., Perez, J. L., Walter, E. B., Senders, S., Bailey, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107456 · Cited by 889 · see citing works
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Shrotri, M., Navaratnam, A. M. D., Nguyen, V., Byrne, T., Geismar, C., Fragaszy, E., Beale, S., Fong, W. L. E., Patel, P., Kovar, J., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01642-1 · Cited by 393 · see citing works
Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents
Ali, K., Berman, G., Zhou, H., Deng, W., Faughnan, V., Coronado-Voges, M., Ding, B., Dooley, J., Girard, B., Hillebrand, W., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2109522 · Cited by 377 · see citing works
Chodick, G., Tene, L., Patalon, T., Gazit, S., Ben‐Tov, A., Cohen, D., & Muhsen, K. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.15985 · Cited by 185 · see citing works
Glatman‐Freedman, A., Bromberg, M., Dichtiar, R., Hershkovitz, Y., & Keinan‐Boker, L. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103574 · Cited by 53 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Fiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.005 · Cited by 911 · see citing works
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
Walter, E. B., Talaat, K. R., Sabharwal, C., Gurtman, A., Lockhart, S., Paulsen, G. C., Barnett, E. D., Muñoz, F. M., Maldonado, Y., Pahud, B. A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2116298 · Cited by 593 · see citing works
Zeng, B., Gao, L., Zhou, Q., Yu, K., & Sun, F. (2022) · BMC Medicine · doi:10.1186/s12916-022-02397-y · Cited by 267 · see citing works
BNT162b2 Protection against the Omicron Variant in Children and Adolescents
Price, A. M., Olson, S. M., Newhams, M. M., Halasa, N. B., Boom, J. A., Sahni, L. C., Pannaraj, P. S., Irby, K., Bline, K., Maddux, A. B., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2202826 · Cited by 226 · see citing works
Chi, W.-Y., Li, Y.-D., Huang, H., Chan, T. E. H., Chow, S.-Y., Su, J.-H., Ferrall, L., Hung, C., & Wu, T. ‐. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00853-8 · Cited by 216 · see citing works
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents
Olson, S. M., Newhams, M. M., Halasa, N. B., Price, A. M., Boom, J. A., Sahni, L. C., Pannaraj, P. S., Irby, K., Walker, T. C., Schwartz, S. P., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2117995 · Cited by 193 · see citing works
Olson, S. M., Newhams, M. M., Halasa, N., Price, A. M., Boom, J. A., Sahni, L. C., Irby, K., Walker, T. C., Schwartz, S. P., Pannaraj, P. S., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7042e1 · Cited by 101 · see citing works
Britton, A., Fleming-Dutra, K. E., Shang, N., Smith, Z., Dorji, T., Derado, G., Accorsi, E. K., Ajani, U. A., Miller, J., Schrag, S. J., et al. (2022) · JAMA · doi:10.1001/jama.2022.2068 · Cited by 91 · see citing works
Effectiveness of BNT162b2 against COVID-19 in adolescents
Powell, A. A., Kirsebom, F., Stowe, J., McOwat, K., Saliba, V., Ramsay, M. E., Lopez-Bernal, J., Andrews, N., & Ladhani, S. N. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00177-3 · Cited by 69 · see citing works
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents
Choe, Y. J., Yi, S., Hwang, I., Kim, J., Park, Y.-J., Cho, E., Jo, M., Lee, H., & Choi, E. H. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.12.044 · Cited by 49 · see citing works
Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response
Wang, X., Yuen, T. T., Dou, Y., Hu, J., Li, R., Zeng, Z., Lin, X., Gong, H., Chan, C. H.-C., Yoon, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39096-y · Cited by 42 · see citing works
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
Du, L., Yang, Y., Zhang, X., & Li, F. (2021) · Nanoscale · doi:10.1039/d1nr03831a · Cited by 41 · see citing works
Sadeghi, S., Kalantari, Y., Shokri, S., Fallahpour, M., Nafissi, N., Goodarzi, A., & Valizadeh, R. (2022) · Journal of Clinical Virology · doi:10.1016/j.jcv.2022.105196 · Cited by 39 · see citing works
Castelli, J. M., Rearte, A., Olszevicki, S., Voto, C. J., Juárez, M. D. V., Pesce, M., Iovane, A. N., Paz, M., Chaparro, M. E., Buyayisqui, M. P., et al. (2022) · BMJ · doi:10.1136/bmj-2022-073070 · Cited by 38 · see citing works
Marra, A. R., Kobayashi, T., Suzuki, H., Alsuhaibani, M., Hasegawa, S., Tholany, J., Perencevich, E. N., Maezato, A. M., Ricardo, V. C. V., Salinas, J. L., et al. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.336 · Cited by 37 · see citing works
González, S. E., Olszevicki, S., Gaiano, A., Baino, A. N. V., Regairaz, L., Salazar, M. R., Pesci, S. A., Marín, L., González, V., Varela, T., et al. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100316 · Cited by 34 · see citing works
Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis
Xu, W., Tang, J., Chen, C., Wang, C., Wen, W., Cheng, Y., Zhou, M., Wu, Q., Zhang, X., Feng, Z., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.01.032 · Cited by 31 · see citing works
Marra, A. R., Miraglia, J. L., Malheiros, D. T., Guozhang, Y., Teich, V., Victor, E. D. S., Pinho, J. R. R., Cypriano, A. S., Vieira, L. W., Polonio, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac430 · Cited by 24 · see citing works
Gao, P., Kang, L., Liu, J., & Liu, M. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-022-00680-9 · Cited by 26 · see citing works
Rudan, I., Adeloye, D., Katikireddi, S. V., Murray, J., Simpson, C. R., Shah, S. A., Robertson, C., & Sheikh, A. (2021) · Journal of Global Health · doi:10.7189/jogh.11.01011 · Cited by 24 · see citing works
Glatman‐Freedman, A., Bromberg, M., Hershkovitz, Y., Sefty, H., Kaufman, Z., Dichtiar, R., & Keinan‐Boker, L. (2022) · Emerging infectious diseases · doi:10.3201/eid2805.220141 · Cited by 25 · see citing works
Self-citationMolteni, E., Canas, L. S., Kläser, K., Deng, J., Bhopal, S., Hughes, R. C., Chen, L., Murray, B. A. K., Kerfoot, E., Antonelli, M., et al. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100429 · Cited by 25 · see citing works
Sabu, J. M., Zahid, I., Jacob, N., Alele, F. O., & Malau‐Aduli, B. S. (2022) · Vaccines · doi:10.3390/vaccines10111880 · Cited by 24 · see citing works
Veneti, L., Berild, J. D., Watle, S. V., Starrfelt, J., Greve‐Isdahl, M., Langlete, P., Bøås, H., Bragstad, K., Hungnes, O., & Meijerink, H. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.03.004 · Cited by 24 · see citing works
Ionescu, I. G., Skowronski, D. M., Sauvageau, C., Chuang, E., Ouakki, M., Kim, S. H., & Serres, G. D. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad006 · Cited by 20 · see citing works
Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel
Prunas, O., Weinberger, D. M., Pitzer, V. E., Gazit, S., & Patalon, T. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac315 · Cited by 19 · see citing works
Veneti, L., Berild, J. D., Watle, S. V., Starrfelt, J., Greve‐Isdahl, M., Langlete, P., Bøås, H., Bragstad, K., Hungnes, O., & Meijerink, H. (2022) · medRxiv · doi:10.1101/2022.03.24.22272854 · Cited by 19 · see citing works
Wiedermann, M., Rose, A. H., Maier, B. F., Kolb, J. J., Hinrichs, D., & Brockmann, D. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad223 · Cited by 19 · see citing works
Eick-Cost, A. A., Ying, S., & Wells, N. Y. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.8071 · Cited by 16 · see citing works
Waning Effectiveness of the BNT162b2 Vaccine Against Infection in AdolescentsPreprint
Prunas, O., Weinberger, D. M., Pitzer, V. E., Gazit, S., & Patalon, T. (2022) · medRxiv · doi:10.1101/2022.01.04.22268776 · Cited by 16 · see citing works
Rudan, I., Millington, T., Antal, K., Grange, Z., Fenton, L., Sullivan, C. B., Buelo, A., Wood, R., Woolford, L., Swann, O. V., et al. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100513 · Cited by 15 · see citing works
OLIVEIRA, E. A., Oliveira, M. C. L., Colosimo, E. A., Silva, A. C. S. E., MAK, R. H. K., Vasconcelos, M. A., Silva, L. R., Martelli, D. R. B., Pinhati, C. C., & Martelli‐Júnior, H. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.09.039 · Cited by 14 · see citing works
Ziv, A., Heshin‐Bekenstein, M., Haviv, R., Kivity, S., Netzer, D., Yaron, S., Schur, Y., Egert, T., Egert, Y., Sela, Y., et al. (2022) · Lara D. Veeken · doi:10.1093/rheumatology/keac408 · Cited by 13 · see citing works
Matson, R. P., Niesen, M. J. M., Levy, E. R., Opp, D. N., Lenehan, P. J., Donadio, G., O’Horo, J. C., Venkatakrishnan, A., Badley, A. D., & Soundararajan, V. (2023) · The Lancet Digital Health · doi:10.1016/s2589-7500(22)00253-9 · Cited by 13 · see citing works
Glatman‐Freedman, A., Hershkovitz, Y., Dichtiar, R., Rosenberg, A., Keinan‐Boker, L., & Bromberg, M. (2023) · Emerging infectious diseases · doi:10.3201/eid2904.221285 · Cited by 12 · see citing works
Self-citationAlhuzaimi, A., Alrasheed, A. A., Al-Eyadhy, A. A., Aljamaan, F., Alhasan, K. A., Batais, M. A., Jamal, A. A., Alshahrani, F. S., Alenezi, S., Alhaboob, A. A. N., et al. (2023) · Healthcare · doi:10.3390/healthcare11070972 · Cited by 11 · see citing works
COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review
FERGIE, J. E., Moran, M. M., Cane, A. D., Pather, S., Türeci, Ö., & Srivastava, A. K. (2022) · Vaccines · doi:10.3390/vaccines10122039 · Cited by 10 · see citing works
Effectiveness of mRNA COVID-19 Vaccines in Adolescents Over 6 Months
Amodio, E., Genovese, D., Mazzeo, L., Martino, L., Restivo, V., Vella, G., Calamusa, G., & Vitale, F. M. (2022) · PEDIATRICS · doi:10.1542/peds.2022-057394 · Cited by 9 · see citing works
Hookham, L., Lee, H. C., Patel, D. A., Coelho, M., Giglio, N., Doaré, K. L., & Pannaraj, P. S. (2022) · Vaccines · doi:10.3390/vaccines11010078 · Cited by 9 · see citing works
Glikman, D., Stein, M., & Shinwell, E. S. (2021) · Acta Paediatrica · doi:10.1111/apa.16157 · Cited by 8 · see citing works
Sariol, C. A., Serrano-Collazo, C., Ortiz, E. J., Pantoja, P., Cruz, L. A., Arana, T., Atehortua, D., Pabon-Carrero, C., & Espino, A. M. (2021) · Viruses · doi:10.3390/v13122405 · Cited by 7 · see citing works
El-Menyar, A. A., Khan, N. A., Mekkodathil, A. A., Rizoli, S. B., Consunji, R. J., Elmenyar, E., Galwankar, S. C., & Al-Thani, H. A. S. (2022) · Medicine · doi:10.1097/md.0000000000030609 · Cited by 7 · see citing works
Müller, G. C., Ferreira, L. S., Campos, F. E. M., Borges, M. E., de Almeida, G. B., Poloni, S., Simon, L. M., Bagattini, Â. M., da Rosa, M. Q. M., Diniz‐Filho, J. A. F., et al. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100396 · Cited by 7 · see citing works
Lessons from the COVID‐19 pandemic: Mortality impacts in Poland versus European Union
Kundzewicz, Z. W., Ebi, K. L., & Duszyński, J. (2023) · Risk Analysis · doi:10.1111/risa.14259 · Cited by 7 · see citing works
COVID-19 in children: epidemic issues and candidate vaccines
Zhang, P., Wei, M., Jing, P., Li, Z., Li, J., & Zhu, F. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002169 · Cited by 6 · see citing works
Glatman‐Freedman, A., Feldman, S. F., Hershkovitz, Y., Kaufman, Z., Dichtiar, R., Keinan‐Boker, L., & Bromberg, M. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac524 · Cited by 5 · see citing works
Self-citationGonzález, S. E., Olszevicki, S., Gaiano, A., Varela, A. N., Regairaz, L., Salazar, M. R., Pesci, S. A., Marín, L., González, V., Varela, T., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4087375 · Cited by 5 · see citing works
Jeremiah, M., Setiadi, A., & Havidz, S. A. H. (2023) · Organizations and Markets in Emerging Economies · doi:10.15388/omee.2023.14.88 · Cited by 4 · see citing works
Marra, A. R., Kobayashi, T., Suzuki, H., Alsuhaibani, M., Schweizer, M. L., Diekema, D. J., Tofaneto, B. M., Bariani, L. M., Auler, M. D. A., Salinas, J. L., et al. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2021.261 · Cited by 4 · see citing works
Marra, A. R., Miraglia, J. L., Malheiro, D. T., Guozhang, Y., Teich, V., Victor, E. D. S., Pinho, J. R. R., Cypriano, A. S., Vieira, L. W., Polonio, M., et al. (2023) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2023.173 · Cited by 3 · see citing works
Is vaccination against COVID-19 a Christian duty? A risk-analytic approach
Fleßa, S. (2021) · Christian Journal for Global Health · doi:10.15566/cjgh.v8i2.611 · Cited by 3 · see citing works
Expert Consensus on COVID-19 Vaccination in Korean Adolescents: A Modified Delphi Survey
Choi, J. H., Moon, J., Kim, S., Bae, H., Lee, J., & Choe, Y. J. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e69 · Cited by 3 · see citing works
Chotpitayasunondh, T., Fisher, D. A., Hsueh, P., Lee, P., Crespo, K. A. N., & Ruxrungtham, K. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2030024 · Cited by 3 · see citing works
Choi, S., Yu, S., Kim, J., Choi, M., Choi, Y. Y., Choi, J. H., Yun, K. W., & Choe, Y. J. (2024) · Pediatric Infection & Vaccine · doi:10.14776/piv.2024.31.e16 · Cited by 2 · see citing works
Rudan, I., Kerr, S., Sullivan, C., Jeffrey, K., Grange, Z., Fenton, L., Kurdi, A. B., Shi, T., Cullen, L. A., Simpson, C. R., et al. (2025) · Journal of Global Health · doi:10.7189/jogh.15.04250 · Cited by 2 · see citing works
Bloise, S., Marcellino, A., Martucci, V., Sanseviero, M., Testa, A., Giudice, E. D., Spatuzzo, M., Sermoneta, D., Ventriglia, F., & Lubrano, R. (2022) · Children · doi:10.3390/children9070993 · Cited by 2 · see citing works
Harahap, A. R. N. (2022) · Indonesian Journal of Nursing and Health Sciences · doi:10.37287/ijnhs.v3i1.906 · Cited by 2 · see citing works
BNT162b2 effectiveness against Delta & Omicron variants in teens by dosing interval and durationPreprint
Ionescu, I. G., Skowronski, D. M., Sauvageau, C., Chuang, E., Ouakki, M., Kim, S. H., & Serres, G. D. (2022) · medRxiv · doi:10.1101/2022.06.27.22276790 · Cited by 2 · see citing works
Bager, M. D., Andersen, M. P., Krogager, M. L., Schou, M., Kragholm, K. H., Fosbøl, E. L., Køber, L., & Torp-Pedersen, C. T. (2025) · Public Health · doi:10.1016/j.puhe.2025.105935 · Cited by 1 · see citing works
Mevorach, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00019-0 · Cited by 1 · see citing works
Impact of vaccination against SARS-CoV-2 on the incidence of infection in school settings
Herrero-Diez, M. T., Salado-Valdivieso, M. I., Carbajal-Domínguez, S., Allué-Tango, M., Villa-Caballero, J. C., & Berbel, C. (2023) · Vacunas (English Edition) · doi:10.1016/j.vacune.2023.06.002 · Cited by 1 · see citing works
Gregorio, G. V., Catacutan, A. M. B., Perez, M. L. M., & Leonila F. Dans, M. (2024) · Acta Medica Philippina · doi:10.47895/amp.v58i7.7930 · Cited by 1 · see citing works
SARS-CoV-2 Delta variant: a systematic review of transmissibility and severity in children
Honeyman, D. A., Buisson, E., Hutchinson, D., Kunasekaran, M. P., Aagerup, J., Chen, X., Moa, A., & Hyde, Z. (2022) · Global Biosecurity · doi:10.31646/gbio.169
Triage performance in adolescent patients with SARS-CoV-2 infection in Israel
Levy, N., Friedman, N., Kaplan, O., Padeh, G., Krupik, D., Buchshtav, N., Gamsu, S., Weiser, G., Cohen, N. K., Schnapp, Z., et al. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.06.061
COVID-19 vaccinations for children and adolescents
Nicolopoulos, K., Sharma, K., Deng, L., & Koirala, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95059-6.00002-4
Impacto de la vacunación contra SARS-CoV-2 en la incidencia de infección en ámbito escolar
Herrero-Diez, M. T., Salado-Valdivieso, M. I., Carbajal-Domínguez, S., Allué-Tango, M., Villa-Caballero, J. C., & Berbel, C. (2023) · Vacunas · doi:10.1016/j.vacun.2023.02.003
Study Effects of Covid_19 Transmission And The Characteristics On Fertility
Shamran, S. G. (2023) · BASRA JOURNAL OF SCIENCE · doi:10.29072/basjs.20230204
Kashef, A., Fakih, L., Bailey, H., Harling, G., & Jackson, C. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5256836
Zeng, B., Gao, L., Zhou, Q. X., Yu, K., & Sun, F. (2022) · Figshare · doi:10.6084/m9.figshare.19845824
Baran, M. F., Aslanlar, D. A., & Gönen, M. Ö. (2026) · Kastamonu Medical Journal · doi:10.66235/kumj.1866154
- Authors
- Glatman-Freedman, A., Hershkovitz, Y., Kaufman, Z., Dichtiar, R., Keinan-Boker, L., & Bromberg, M.
- Affiliations
- Tel Aviv University (IL)
- Venue
- Emerging Infectious Diseases
- Published
- 2021-11
- Volume
- 27
- Issue
- 11
- Pages
- 2919-2922
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- PMC
- PMC8544958
- OpenAlex
- W3203244191
- Cited by
- 70
- References
- 7
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 16 · 2022: 39 · 2021: 9
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Emerging infectious diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- BNT162b2, COVID-19 vaccine effectiveness, adolescents, Delta variant, breakthrough infection, Israel
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, BNT162 Vaccine, Adolescent, Disease Outbreaks, Humans, Israel, Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
